3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Breast Neoplasms
931
Neoplasms
705
Prostatic Neoplasms
487
Lung Neoplasms
390
Colorectal Neoplasms
359
Carcinoma, Non-Small-Cell Lung
356
Leukemia, Myeloid, Acute
278
Pancreatic Neoplasms
233
Brain Neoplasms
223
Neoplasm Metastasis
221
Multiple Myeloma
214
Carcinoma, Hepatocellular
199
Head and Neck Neoplasms
185
Precursor Cell Lymphoblastic Leukemia-Lymphoma
180
Glioblastoma
180
Melanoma
173
Ovarian Neoplasms
167
Squamous Cell Carcinoma of Head and Neck
158
Recurrence
143
Rectal Neoplasms
142
Uterine Cervical Neoplasms
140
Sarcoma
134
Hematologic Neoplasms
131
Glioma
128
Stomach Neoplasms
127
Triple Negative Breast Neoplasms
126
Carcinoma, Renal Cell
123
Esophageal Neoplasms
109
Colonic Neoplasms
109
Myelodysplastic Syndromes
107
Interventions
temsirolimus
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Patients With Advanced or Metastatic Solid Tumors
×
90 days
×
Clear all
NCT02215720
2026-03-20
TORERO
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1
Completed
45 enrolled